Douglas V. Faller, MD, PhD
Professor
Boston University School of Medicine
Dept of Medicine
Hematology & Medical Oncology Section

MD, Harvard University
PhD, Massachusetts Institute of Technology



Professor
Boston University School of Medicine
Department of Pathology & Laboratory Medicine


Active Staff Privileges
Boston Medical Center
Department of Medicine
Hematology & Medical Oncology Section



Boston University Cross-Disciplinary Training in Nanotechnology for Cancer
09/01/2010 - 07/31/2016 (Co-PI)
NIH/National Cancer Institute
5R25CA153955-05

Targeting N-RAS as a Therapeutic Approach for Melanoma
05/01/2012 - 04/30/2016 (PI)
Melanoma Research Alliance

PKC-Inhibitors as Targeted Therapeutics for Systemic Sclerosis
01/15/2014 - 01/14/2016 (PI)
Scleroderma Foundation

Non-Oncogene Addiction as a Targeted Therapy for Pancreatic Cancer
01/01/2013 - 12/31/2015 (PI)
NIH/National Cancer Institute
5R21CA164245-02

Institutional Research Grant
01/01/2012 - 12/31/2015 (PI of Sub-Project / SP)
PI: Avrum Spira, MD
American Cancer Society - MA Division

Mechanisms of Action and Signaling by Steroid Hormone Antagonists
06/01/2003 - 12/31/2015 (PI)
NIH/National Cancer Institute
5R01CA101992-09

Targeting N-Ras as a Terapeutic Approach to Melanoma
09/30/2012 - 09/29/2014 (PI)
Department of Defense/Army Medical Research Acquisition Activity

Synthetic Lethality as a Targeted Approach to Advanced Prostate Cancer
03/01/2011 - 02/28/2014 (PI)
Department of Defense/Army

Virus-Targeted Therapy for Malignancies
09/26/2011 - 08/31/2012 (PI)
Phoenicia Biosciences, Inc. NIH NCI
R43CA153474-01A1

Virus-Targeted Therapeutic for Epstein-Barr Virus-Associated Lymphomas
08/01/2009 - 07/31/2012 (PI)
V Foundation

Showing 10 of 40 results. Show All Results

SWOG - Clinical Trials Initiative
02/28/2009 - 02/28/2017 (PI)
South West Oncology Group NIH-NCI

SWOG - NCI
02/23/2004 - 02/28/2017 (PI)
South West Oncology Group

SWOG Master Agreement
02/26/2014 - 02/25/2017 (PI)
Oregon Health and Science University NIH-NCI



Yr Title Project-Sub Proj Pubs
2014 Non-Oncogene Addiction as a Targeted Therapy for Pancreatic Cancer 5R21CA164245-02 5
2014 Boston University Cross-Disciplinary Training in Nanotechnology for Cancer 5R25CA153955-05 29
2014 Boston University Cross-Disciplinary Training in Nanotechnology for Cancer 3R25CA153955-05S1 29
2014 Boston University Cross-Disciplinary Training in Nanotechnology for Cancer 3R25CA153955-05S2 29
2013 Non-Oncogene Addiction as a Targeted Therapy for Pancreatic Cancer 1R21CA164245-01A1 5
2013 Boston University Cross-Disciplinary Training in Nanotechnology for Cancer 5R25CA153955-04 29
2013 Boston University Cross-Disciplinary Training in Nanotechnology for Cancer 3R25CA153955-04S1 29
2013 Boston University Cross-Disciplinary Training in Nanotechnology for Cancer 3R25CA153955-04S2 29
2013 Mechanisms of Action and Signaling by Steroid Hormone Antagonists 5R01CA101992-09 17
2012 Boston University Cross-Disciplinary Training in Nanotechnology for Cancer 5R25CA153955-03 29
Showing 10 of 88 results. Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Lin HM, Gao X, Cooke CE, Berg D, Labotka R, Faller DV, Seal B, Hari P. Disease burden of systemic light-chain amyloidosis: a systematic literature review. Curr Med Res Opin. 2017 Jun; 33(6):1017-1031. PMID: 28277869; DOI: 10.1080/03007995.2017.1297930;.
  2. Faller DV, Castaneda SA, Zhou D, Vedamony M, Newburger PE, White GL, Kosanke S, Plett PA, Orschell CM, Boosalis MS, Perrine SP. An oral HemokineTM, a-methylhydrocinnamate, enhances myeloid and neutrophil recovery following irradiation in vivo. Blood Cells Mol Dis. 2017 Mar; 63:1-8.View Related Profiles. PMID: 27888688; DOI: 10.1016/j.bcmd.2016.10.021;.
  3. Moos WH, Pinkert CA, Irwin MH, Faller DV, Kodukula K, Glavas IP, Steliou K. Epigenetic Treatment of Persistent Viral Infections. Drug Dev Res. 2017 Feb; 78(1):24-36. PMID: 27761936; DOI: 10.1002/ddr.21366;.
  4. Moos WH, Faller DV, Harpp DN, Kanara I, Pernokas J, Powers WR, Steliou K. Microbiota and Neurological Disorders: A Gut Feeling. Biores Open Access. 2016; 5(1):137-45. PMID: 27274912; DOI: 10.1089/biores.2016.0010;.
  5. Irwin MH, Moos WH, Faller DV, Steliou K, Pinkert CA. Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases. Drug Dev Res. 2016 May; 77(3):109-23. PMID: 26899010; DOI: 10.1002/ddr.21294;.
  6. Moos WH, Maneta E, Pinkert CA, Irwin MH, Hoffman ME, Faller DV, Steliou K. Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia. Drug Dev Res. 2016 Mar; 77(2):53-72. PMID: 26899191; DOI: 10.1002/ddr.21295;.
  7. Boosalis MS, Sangerman JI, White GL, Wolf RF, Shen L, Dai Y, White E, Makala LH, Li B, Pace BS, Nouraie M, Faller DV, Perrine SP. Novel Inducers of Fetal Globin Identified through High Throughput Screening (HTS) Are Active In Vivo in Anemic Baboons and Transgenic Mice. PLoS One. 2015; 10(12):e0144660.View Related Profiles. PMID: 26713848; PMCID: PMC4694699; DOI: 10.1371/journal.pone.0144660;.
  8. Dai Y, Sangerman J, Luo HY, Fucharoen S, Chui DH, Faller DV, Perrine SP. Therapeutic fetal-globin inducers reduce transcriptional repression in hemoglobinopathy erythroid progenitors through distinct mechanisms. Blood Cells Mol Dis. 2016 Jan; 56(1):62-9.View Related Profiles. PMID: 26603726; PMCID: PMC4667977; DOI: 10.1016/j.bcmd.2015.10.004;.
  9. Cao J, Dai X, Wan L, Wang H, Zhang J, Goff PS, Sviderskaya EV, Xuan Z, Xu Z, Xu X, Hinds P, Flaherty KT, Faller DV, Goding CR, Wang Y, Wei W, Cui R. The E3 ligase APC/C(Cdh1) promotes ubiquitylation-mediated proteolysis of PAX3 to suppress melanocyte proliferation and melanoma growth. Sci Signal. 2015 Sep 1; 8(392):ra87.View Related Profiles. PMID: 26329581; DOI: 10.1126/scisignal.aab1995;.
  10. Steliou K, Faller DV, Pinkert CA, Irwin MH, Moos WH. Bioprotective carnitinoids: lipoic acid, butyrate, and mitochondria-targeting to treat radiation injury: mitochondrial drugs come of age. Drug Dev Res. 2015 Jun; 76(4):167-75. PMID: 26109467; DOI: 10.1002/ddr.21258;.
Showing 10 of 269 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 247 publications over 35 distinct years, with a maximum of 16 publications in 1988 and 1995

YearPublications
19831
19842
19855
19867
198715
198816
19896
19909
19919
19923
19935
199410
199516
199613
199710
19987
19999
20007
20017
20029
20034
20042
20055
200610
20076
20089
20099
20104
20117
20125
20134
20146
20154
20165
20171
Contact for Mentoring:


72 E. Concord St Silvio Conte (K)
Boston MA 02118
Google Map


Faller's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department